Anti-IL-12/23 [ABT-874 (Briakinumab)]
Ab00722-10.0
ApplicationsNeutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetIL12B
Overview
- SupplierAbsolute Antibody
- Product NameAnti-IL-12/23 [ABT-874 (Briakinumab)]
- Delivery Days Customer7
- Antibody SpecificityBinds to human IL12 and IL23 via IL-12/23p40.
- Application Supplier NoteThis antibody binds to and neutralises human IL12 and IL23.
- ApplicationsNeutralisation/Blocking
- Applications Supplierblock
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDABT-874 (Briakinumab)
- Gene ID3593
- Target nameIL12B
- Target descriptioninterleukin 12B
- Target synonymsCLMF; CLMF p40; CLMF2; cytotoxic lymphocyte maturation factor 40 kDa subunit; IL-12 subunit p40; IL12, subunit p40; IL-12B; IMD28; IMD29; interleukin 12, p40; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); interleukin-12 beta chain; interleukin-12 subunit beta; natural killer cell stimulatory factor, 40 kD subunit; NK cell stimulatory factor chain 2; NKSF; NKSF2
- HostHuman
- IsotypeIgG1
- Protein IDP29460
- Protein NameInterleukin-12 subunit beta
- ReactivityHuman
- Reactivity SupplierHuman
- Reactivity Supplier NoteThis antibody was generated by phage display technology.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203